Kinjo Yasuyuki, Yoshimura Kazuaki, Suzuki Takashi, Shinozawa Keiko, Nakasone Kei, Yoshimata Tetsushi, Nishihira Moriki, Henzan Eitatsu
Department of Internal Medicine, Nanbu Tokushukai Hospital.
Rinsho Ketsueki. 2014 Nov;55(11):2311-5.
Acquired factor V (FV) inhibitor is a rare coagulation disorder, the causes and clinical symptoms of which are known to vary widely. Acquired FV inhibitor mostly occurs with exposure to fibrin glues during surgical procedures. We experienced a case with asymptomatic acquired FV inhibitor caused by antibiotic therapy for aspiration pneumonia.A man in his eighties had been treated for chronic atrial fibrillation, cerebral infarction and spinal canal stenosis. He was admitted after antibiotic therapy for aspiration pneumonia in a previous hospital. On admission, the screening test for blood coagulation revealed extreme prolongation of both prothrombin time (PT) and activated partial thromboplastin time (APTT). Vitamin K was administered intravenously after cessation of warfarin, but neither PT nor APTT showed any improvement. Subsequently, a cross mixing test was performed and showed an inhibitor pattern. Furthermore, a high titer of FV inhibitor was detected by the Bethesda method and an acquired FV inhibitor was thus diagnosed. Despite the presence of FV inhibitor, the patient showed no bleeding symptoms. Eight months later, both PT and APTT had diminished to normal clotting time values without immunosuppressive therapies.
获得性凝血因子V(FV)抑制剂是一种罕见的凝血障碍,其病因和临床症状差异很大。获得性FV抑制剂大多在手术过程中接触纤维蛋白胶时发生。我们遇到了一例因吸入性肺炎抗生素治疗导致无症状获得性FV抑制剂的病例。一名八十多岁的男性曾因慢性心房颤动、脑梗死和椎管狭窄接受治疗。他在之前的医院接受吸入性肺炎抗生素治疗后入院。入院时,凝血筛查试验显示凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)均极度延长。停用华法林后静脉注射维生素K,但PT和APTT均未显示任何改善。随后进行了交叉混合试验,结果显示为抑制剂模式。此外,通过贝塞斯达法检测到高滴度的FV抑制剂,从而诊断为获得性FV抑制剂。尽管存在FV抑制剂,但患者未出现出血症状。八个月后,未经免疫抑制治疗,PT和APTT均降至正常凝血时间值。